However, approximately 50% of TMZ-treated GBM patients do not respond to TMZ because their tumors overexpressed O6-Methylguanine-DNA Methyltransferase (MGMT), and most patients experience serious side effects including bone marrow suppression and female infertility [25–27]. Here, MGMT is linked to glioblastoma.